N@N

David Roman Initiated (TNDM) at Hold and Held Target at $46 on, Oct 4th, 2024

David Roman of Goldman Sachs, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Hold and Held Target at $46 on, Oct 4th, 2024.

David has made no other calls on TNDM in the last 4 months.

There are 8 other peers that have a rating on TNDM. Out of the 8 peers that are also analyzing TNDM, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Patrick Wood of "Morgan Stanley" Maintained at Hold and Held Target at $45 on, Monday, September 23rd, 2024
• Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $39 on, Friday, August 2nd, 2024

These are the ratings of the 6 analyists that currently disagree with David

---

• Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $65 on, Wednesday, October 2nd, 2024
• William Plovanic of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $57 on, Thursday, August 8th, 2024
• Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $58 on, Monday, August 5th, 2024
• Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
• Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
• Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $58 on, Monday, June 10th, 2024

Contributing Sources

---